Mouth Guard Use in the Second Stage of Labor

July 31, 2020 updated by: Christiana Care Health Services

Mouth Guard Use in the Second Stage of Labor: A Randomized Controlled Trial

Shortening the second stage of labor, the time spent pushing the baby out, is important for positive mother and infant's outcomes. Lack of progress of labor for any reason is the most common reason for cesarean section in women having their first baby and the second most common reason for cesarean section in women who have already had a baby. In 2014, a large study done across the United States showed increases in complications in both mother and infant when pushing was prolonged, including uterine infection, postpartum hemorrhage, more extensive vaginal tearing, shoulder dystocia, 5 minute Apgar score less than 4, infant admission to Neonatal Intensive Care Unit and neonatal infections. Therefore, the challenge is to consider alternative practices in order to maximize a mother's chance of a vaginal delivery and minimize these associated risks to both mother and baby.

Mouth guards are used primarily in contact sports, and have been demonstrated to reduce or prevent injury to the teeth. Additionally, it has been proposed that wearing a mouth guard increases the strength of different muscle groups. A recent randomized controlled pilot study including women with their first pregnancy using a dental support device (DSD) during the second stage of labor evaluated the length of the second stage and outcomes. They found a significant decrease of 38% in the length of pushing time in the group that used a DSD. Additionally, there was a decreased rate of cesarean section in this group, however a p-value was not reported. This study only included 64 patients. A second, larger trial did not find a significant difference in pushing time, however the rate of interventions such as a vacuum or forceps-assisted vaginal delivery and cesarean section were much higher in the control group due to prolonged pushing. The results of the second study are contradictory in nature, yet the researchers do not provide hypotheses into why this may be.

It is clear from the previously mentioned studies that further research is needed. Our hypothesis is that using such a device would help women to push more effectively during the second stage of labor thus shortening the time needed to push the baby out and increasing the rate of vaginal delivery. The purpose of this study is to determine whether wearing a mouth guard in the second stage of labor affects the length of the second stage of labor and improves mother & infant outcomes.

Study Overview

Detailed Description

Optimizing the second stage of labor is important for positive maternal and neonatal outcomes. Dystocia of labor refers to a lack of progress of labor for any reason, and it is the most common indication for cesarean delivery in nulliparous women and the second most common indication for cesarean delivery in multiparous women. In 2014, a large US multicenter cohort study showed increases in maternal and neonatal morbidities when the second stage was prolonged, including chorioamnionitis, postpartum hemorrhage, 3rd and 4th degree perineal laceration, shoulder dystocia, 5 minute Apgar score less than 4, neonatal admission to NICU and neonatal sepsis. Therefore, clinicians are challenged to consider alternative practices in order to maximize a mother's chance of a normal delivery and minimize these associated risks to both mother and baby.

Mouth guards are used primarily in contact sports, and have been demonstrated to reduce or prevent injury to the teeth. Most commonly made of synthetic polymers, mouth guards function as a shock-absorber. Even among sports medicine literature, there is a call for more research into use and education about protective gear. Previous studies have shown that wearing a mouth guard increases the isometric strength of different muscle groups. Recent studies have begun to explore whether wearing a similar style mouth guard will shorten the duration of the second stage of labor. A recent randomized controlled pilot study including nulliparous women using a dental support device (DSD) during the second stage evaluated the length of the second stage and outcome thereof. They defined the second stage of labor as the time between complete cervical dilation and fetal expulsion. They found a significant decrease of 38% in the length of the second stage in the group that used a DSD. Additionally, there was a decreased rate of cesarean section in this group, however a p-value was not reported. This study only included 64 patients. A second, larger trial also looking at nulliparous women did not find a significant difference in length of second stage of labor however the rate of obstetrical interventions such as operative vaginal delivery and cesarean section were much higher in the control group due to prolonged second stage of labor. Though the results of the second study are contradictory in nature, the researchers do not provide hypotheses into why this may be.

Our hypothesis is that using such a device would help women to push more effectively during the second stage of labor thus shortening the second stage and increasing the rate of spontaneous vaginal deliveries that do not require operative intervention. Developing a way to shorten the second stage of labor and reduce the number of cesarean sections or instrumental deliveries could reduce the morbidity of mothers and their infants and decrease health care spending.

Study Type

Interventional

Enrollment (Actual)

154

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Delaware
      • Newark, Delaware, United States, 19713
        • Christiana Care Health System

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Nulliparous women
  • Age 18-55
  • Presenting for delivery at Christiana Care Health Services
  • Singleton pregnancy
  • Cephalic pregnancy
  • Term pregnancy

Exclusion Criteria:

  • Multiple gestation
  • Known uterine anomalies, excluding resected uterine septums and fibroids
  • Estimated fetal weight less than 10th% for gestation age with abnormal umbilical dopplers
  • Estimated fetal weight less than the 5th percentile
  • History of cardiac disease requiring assisted second stage of labor
  • Oral implants, braces or active dental infection precluding mouth guard use
  • Preeclampsia with severe features treated with magnesium sulfate
  • History of shoulder dystocia
  • History of myomectomy
  • Maternal history of myasthenia gravis
  • Maternal history of sleep apnea with home CPAP use
  • Category III fetal heart tracing
  • Active vaginal bleeding consistent with placental abruption
  • Diagnosis of chorioamnionitis prior to start of second stage of labor
  • Participation in another interventional research study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mouth Guard
Patients will push in the second stage of labor without use of mouth guard
Patient will wear mouth guard while pushing in the second stage of labor
No Intervention: Control
Patients will push in the second stage of labor without use of mouth guard

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time of Second Stage of Labor
Time Frame: Time from full cervical dilation (10cm) to delivery of the fetal head, approximately 2 hours
Time in minutes
Time from full cervical dilation (10cm) to delivery of the fetal head, approximately 2 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mode of Delivery
Time Frame: From time of randomization until delivery, up to one week
Spontaneous vaginal delivery, assisted vaginal delivery, cesarean section
From time of randomization until delivery, up to one week
Instrumental Delivery
Time Frame: From time of randomization until delivery, up to one week
Type of instrument used in assisting delivery
From time of randomization until delivery, up to one week
Patient Satisfaction
Time Frame: From time of randomization until delivery, up to one week
Patient satisfaction with device as measured by survey
From time of randomization until delivery, up to one week
Perineal Laceration
Time Frame: From time of randomization until delivery, up to one week
Degree of perineal laceration with vaginal delivery
From time of randomization until delivery, up to one week
Apgar Score
Time Frame: From 0 to 10 minutes after delivery
Apgar scores of infants at 1, 5, and 10 minutes
From 0 to 10 minutes after delivery
Percentage of Time Spent Using Device
Time Frame: From time of randomization until delivery, up to one week
Provider will estimate percentage of second stage that patient used device
From time of randomization until delivery, up to one week
Neonatal ICU Admission Rate
Time Frame: From time of randomization until delivery, up to one week
Number of infants admitted to the NICU
From time of randomization until delivery, up to one week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elizabeth Shy, MD, Christiana Care Health Services

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 9, 2018

Primary Completion (Actual)

December 1, 2019

Study Completion (Actual)

December 1, 2019

Study Registration Dates

First Submitted

March 23, 2018

First Submitted That Met QC Criteria

May 8, 2018

First Posted (Actual)

May 9, 2018

Study Record Updates

Last Update Posted (Actual)

August 4, 2020

Last Update Submitted That Met QC Criteria

July 31, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 37133

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Plan to submit for publication

IPD Sharing Time Frame

Within one year

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Labor Long

Clinical Trials on Mouth Guard

3
Subscribe